Changing treatment changing prognosis of mutations
- PMID: 37944182
- DOI: 10.1182/blood.2023021769
Changing treatment changing prognosis of mutations
Comment on
-
Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia.Blood. 2023 Nov 9;142(19):1647-1657. doi: 10.1182/blood.2023020649. Blood. 2023. PMID: 37441846
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical